Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Xianguo Kong, Zhao Lin, Dongming Liang, Donna Fath, Nianli Sang & Jaime Caro. (2006) Histone Deacetylase Inhibitors Induce VHL and Ubiquitin-Independent Proteasomal Degradation of Hypoxia-Inducible Factor 1α. Molecular and Cellular Biology 26:6, pages 2019-2028.
Read now
Read now
Peggy Papeleu, Tamara Vanhaecke, Greetje Elaut, Mathieu Vinken, Tom Henkens, Sarah Snykers & Vera Rogiers. (2005) Differential Effects of Histone Deacetylase Inhibitors in Tumor and Normal Cells—What Is the Toxicological Relevance?. Critical Reviews in Toxicology 35:4, pages 363-378.
Read now
Read now
MARY E. GERRITSEN, ROBERT SORIANO, SUYA YANG, CONSTANCE ZLOT, GLADYS INGLE, KAREN TOY & P. MICKEY WILLIAMS. (2003) Branching Out: A Molecular Fingerprint of Endothelial Differentiation into Tube-Like Structures Generated by Affymetrix Oligonucleotide Arrays. Microcirculation 10:1, pages 63-81.
Read now
Read now
Articles from other publishers (29)
Yang Tian, Ning Wan, Hanqing Zhang, Chang Shao, Ming Ding, Qiuyu Bao, Haiyang Hu, Huiyong Sun, Chenguang Liu, Kun Zhou, Shuai Chen, Guangji Wang, Hui Ye & Haiping Hao. (2023) Chemoproteomic mapping of the glycolytic targetome in cancer cells. Nature Chemical Biology 19:12, pages 1480-1491.
Crossref
Crossref
Rui Yuan, Jiang Yu, Ziqiao Jiao, Jinfei Li, Fang Wu, Rongkai Yan, Xiaojie Huang & Chen Chen. (2021) The Roles of Tissue-Resident Memory T Cells in Lung Diseases. Frontiers in Immunology 12.
Crossref
Crossref
Xiaona Chen, Yanhong He, Wenjun Fu, Amirhossein Sahebkar, Yuhui Tan, Suowen Xu & Hong Li. (2020) Histone Deacetylases (HDACs) and Atherosclerosis: A Mechanistic and Pharmacological Review. Frontiers in Cell and Developmental Biology 8.
Crossref
Crossref
Devipriya Nagarajan, Lei Wang, Weiling Zhao & Xiaochen Han. (2017) Trichostatin A inhibits radiation-induced epithelial-to-mesenchymal transition in the alveolar epithelial cells. Oncotarget 8:60, pages 101745-101759.
Crossref
Crossref
Young Jun KimSang Jun ParkNa Rae KimHee Seung Chin. (2017) Effects of Histone Deacetylase Inhibitor (Valproic Acid) on the Expression of Hypoxia-inducible Factor-1 Alpha in Human Retinal Müller Cells. Korean Journal of Ophthalmology 31:1, pages 80.
Crossref
Crossref
Dimitry A. Chistiakov, Alexander N. Orekhov & Yuri V. Bobryshev. (2017) Treatment of cardiovascular pathology with epigenetically active agents: Focus on natural and synthetic inhibitors of DNA methylation and histone deacetylation. International Journal of Cardiology 227, pages 66-82.
Crossref
Crossref
Katrina J. Falkenberg & Ricky W. Johnstone. (2014) Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders. Nature Reviews Drug Discovery 13:9, pages 673-691.
Crossref
Crossref
ZHI-HUA ZHANG, CHANG-LAI HAO, PENG LIU, XIA TIAN, LI-HONG WANG, LEI ZHAO & CUI-MIN ZHU. (2014) Valproic acid inhibits tumor angiogenesis in mice transplanted with Kasumi-1 leukemia cells. Molecular Medicine Reports 9:2, pages 443-449.
Crossref
Crossref
Dong-Dong Cheng, Qing-Cheng Yang, Zhi-Chang Zhang, Cui-Xia Yang & Yi-Wen Liu. (2012) Antitumor Activity of Histone Deacetylase Inhibitor Trichostatin A in Osteosarcoma Cells. Asian Pacific Journal of Cancer Prevention 13:4, pages 1395-1399.
Crossref
Crossref
Abraham Jacob, Janet Oblinger, Matthew L. Bush, Victoria Brendel, Griffin Santarelli, Abhik R. Chaudhury, Samuel Kulp, Krista M. D. La Perle, Ching-Shih Chen, Long-Sheng Chang & D. Bradley Welling. (2012) Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas. The Laryngoscope 122:1, pages 174-189.
Crossref
Crossref
Giuseppe GiacconeArun RajanArlene BermanRonan J. KellyEva SzaboAriel Lopez-ChavezJane TrepelMin-Jung LeeLiang CaoIgor Espinoza-DelgadoJohn SpittlerPatrick J. LoehrerSrSr. (2011) Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors. Journal of Clinical Oncology 29:15, pages 2052-2059.
Crossref
Crossref
Pierre Close, Catherine Creppe, Magali Gillard, Aurélie Ladang, Jean-Paul Chapelle, Laurent Nguyen & Alain Chariot. (2010) The emerging role of lysine acetylation of non-nuclear proteins. Cellular and Molecular Life Sciences 67:8, pages 1255-1264.
Crossref
Crossref
Victoria M. Richon, Jose Garcia-Vargas & James S. Hardwick. (2009) Development of vorinostat: Current applications and future perspectives for cancer therapy. Cancer Letters 280:2, pages 201-210.
Crossref
Crossref
Neta Altman-Price & Moshe Mevarech. (2009)
Genetic Evidence for the Importance of Protein Acetylation and Protein Deacetylation in the Halophilic Archaeon
Haloferax volcanii
. Journal of Bacteriology 191:5, pages 1610-1617.
Crossref
Crossref
Isabelle Jariel-Encontre, Guillaume Bossis & Marc Piechaczyk. (2008) Ubiquitin-independent degradation of proteins by the proteasome. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1786:2, pages 153-177.
Crossref
Crossref
Cinzia Pellizzaro, Annalisa Speranza, Sonia Zorzet, Ilaria Crucil, Gianni Sava, Ignazio Scarlata, Silvia Cantoni, Maya Fedeli & Danila Coradini. (2008) Inhibition of Human Pancreatic Cell Line MIA PaCa2 Proliferation by HA-But, a Hyaluronic Butyric Ester. Pancreas 36:4, pages e15-e23.
Crossref
Crossref
Roya Khosravi-Far & Eileen WhiteSharmila Shankar & Rakesh K. Srivastava. 2008. Programmed Cell Death in Cancer Progression and Therapy. Programmed Cell Death in Cancer Progression and Therapy
261
298
.
Lars C. Huber, Jörg H. W. Distler, Falk Moritz, Hossein Hemmatazad, Thomas Hauser, Beat A. Michel, Renate E. Gay, Marco Matucci‐Cerinic, Steffen Gay, Oliver Distler & Astrid Jüngel. (2007) Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin‐induced skin fibrosis. Arthritis & Rheumatism 56:8, pages 2755-2764.
Crossref
Crossref
Amber Buescher Johnson & Michelle Craig Barton. (2007) Hypoxia-induced and stress-specific changes in chromatin structure and function. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 618:1-2, pages 149-162.
Crossref
Crossref
K. Petrie, N. Prodromou & A. Zelent. 2007. Acute Promyelocytic Leukemia. Acute Promyelocytic Leukemia
157
203
.
Sharmila Shankar & Rakesh K. Srivastava. 2007. Apoptosis, Cell Signaling, and Human Diseases. Apoptosis, Cell Signaling, and Human Diseases
335
361
.
Kenji InoueMika KobayashiKiichiro YanoMai MiuraAkashi IzumiChikage MatakiTakeshi DoiTakao HamakuboPatrick C. ReidDavid A. HumeMinoru YoshidaWilliam C. AirdTatsuhiko KodamaTakashi Minami. (2006) Histone Deacetylase Inhibitor Reduces Monocyte Adhesion to Endothelium Through the Suppression of Vascular Cell Adhesion Molecule-1 Expression. Arteriosclerosis, Thrombosis, and Vascular Biology 26:12, pages 2652-2659.
Crossref
Crossref
Qingzhong XiaoLingfang ZengZhongyi ZhangAndriana MargaritiZiad A AliKeith M. ChannonQingbo XuYanhua Hu. (2006)
Sca-1
+
Progenitors Derived From Embryonic Stem Cells Differentiate Into Endothelial Cells Capable of Vascular Repair After Arterial Injury
. Arteriosclerosis, Thrombosis, and Vascular Biology 26:10, pages 2244-2251.
Crossref
Crossref
Donna M. Fath, Xianguo Kong, Dongming Liang, Zhao Lin, Andrew Chou, Yubao Jiang, Jie Fang, Jaime Caro & Nianli Sang. (2006) Histone Deacetylase Inhibitors Repress the Transactivation Potential of Hypoxia-inducible Factors Independently of Direct Acetylation of HIF-α. Journal of Biological Chemistry 281:19, pages 13612-13619.
Crossref
Crossref
Prakash Chinnaiyan, Sooryanarayana Varambally, Scott A. Tomlins, Soma Ray, Shyhmin Huang, Arul M. Chinnaiyan & Paul M. Harari. (2005) Enhancing the antitumor activity of ErbB blockade with histone deacetylase (HDAC) inhibition. International Journal of Cancer 118:4, pages 1041-1050.
Crossref
Crossref
Milin R. Acharya, Alex Sparreboom, Jürgen Venitz & William D. Figg. (2005) Rational Development of Histone Deacetylase Inhibitors as Anticancer Agents: A Review. Molecular Pharmacology 68:4, pages 917-932.
Crossref
Crossref
HIROSHI UCHIDA, TETSUO MARUYAMA, TORU ARASE, MASANORI ONO, TAKASHI NAGASHIMA, HIROTAKA MASUDA, HIRONORI ASADA & YASUNORI YOSHIMURA. (2005) Histone acetylation in reproductive organs: Significance of histone deacetylase inhibitors in gene transcription. Reproductive Medicine and Biology 4:2, pages 115-122.
Crossref
Crossref
Seong Hwan Kim, Sanghun Ahn, Jeung-Whan Han, Hyang-Woo Lee, Hoi Young Lee, Yin-Won Lee, Mi Ran Kim, Kye Won Kim, Won Bae Kim & Sungyoul Hong. (2004) Apicidin is a histone deacetylase inhibitor with anti-invasive and anti-angiogenic potentials. Biochemical and Biophysical Research Communications 315:4, pages 964-970.
Crossref
Crossref
MARY E. GERRITSEN, ROBERT SORIANO, SUYA YANG, CONSTANCE ZLOT, GLADYS INGLE, KAREN TOY & P. MICKEY WILLIAMS. (2010) Branching Out: A Molecular Fingerprint of Endothelial Differentiation into Tube‐Like Structures Generated by Affymetrix Oligonucleotide Arrays. Microcirculation 10:1, pages 63-81.
Crossref
Crossref